다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Foghorn Therapeutics Inc (FHTX)
Foghorn Therapeutics Inc (FHTX) 뉴스

FHTX

Foghorn Therapeutics (FHTX)

Foghorn Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:FHTX

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/28	20:00	GlobeNewswire Inc.	Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/05/23	20:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/05/23	07:21	GlobeNewswire Inc.	Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance Pipeline	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/05/23	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/05/21	05:31	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/05/20	21:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/05/07	05:54	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/05/06	20:03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/05/06	20:03	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/05/06	20:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/03/07	21:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/03/07	21:09	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/02/08	21:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/01/26	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/01/26	06:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/01/26	06:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/01/26	06:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/01/26	06:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/01/18	06:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/01/08	21:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/01/04	06:18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2023/11/28	09:01	PR Newswire (US)	Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders	NASDAQ:FHTX	Foghorn Therapeutics Inc
2023/11/21	20:00	PR Newswire (US)	Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics	NASDAQ:FHTX	Foghorn Therapeutics Inc
2023/11/02	20:08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FHTX	Foghorn Therapeutics Inc
2023/11/02	20:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2023/11/01	23:30	PR Newswire (US)	Flagship Pioneering Launches Pioneering Intelligence	NASDAQ:FHTX	Foghorn Therapeutics Inc
2023/09/11	19:30	PR Newswire (US)	Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer	NASDAQ:FHTX	Foghorn Therapeutics Inc
2023/09/08	20:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2023/09/05	21:00	GlobeNewswire Inc.	Foghorn Therapeutics Announces Participation in Upcoming Investor Conferences	NASDAQ:FHTX	Foghorn Therapeutics Inc
2023/08/31	20:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc

검색 관련기사 보기:NASDAQ:FHTX

1 2 3 4 5 다음 >>

Tata Power Companies (PK)

Goldplay Mining

Leonteq Securities

Vanguard Lifestrategy 80...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관